On the essentiality of the angiotensin converting enzyme 2 receptor for SARS-CoV-2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID-19.

Hassler, Luise; Penninger, Josef; Batlle, Daniel

Hassler, Luise; Penninger, Josef; Batlle, Daniel.

Hassler L; Division of Nephrology/Hypertension, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Penninger J; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Batlle D; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.

Clin Transl Med ; 12(10): e1080, 2022 Oct.

Article in English | MEDLINE | ID: covidwho-2059367

Subject(s)

Angiotensin-Converting Enzyme 2; COVID-19; Angiotensin-Converting Enzyme Inhibitors; Humans; Peptidyl-Dipeptidase A/genetics; Peptidyl-Dipeptidase A/metabolism; SARS-CoV-2/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme 2 / COVID-19 Topics: Variants Limits: Humans Language: English Journal: Clin Transl Med Year: 2022 Document Type: Article Affiliation country: Ctm2.1080

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google